Practical guide to ethically presenting breakthrough therapies to vulnerable patients: ensure informed consent, explain uncertainty, and minimize coercion.
4 articles found in 0.90s
Practical guide to ethically presenting breakthrough therapies to vulnerable patients: ensure informed consent, explain uncertainty, and minimize coercion.
Learn why FDA 'breakthrough' therapy designation often reflects expedited review, not proven clinical benefit, how to interpret evidence and avoid hype.
Discover how psilocybin is revolutionizing mental health treatment through clinical trials and neuroplasticity insights. Explore its therapeutic potential!